2013‐2016 Movember. Title: PROPS: PET/MRI pre‐radiotherapy for post‐prostatectomy salvage. Amount: $200,000 CAD. [Grants] Principal Inves gator: U Metser. Co‐Inves gator: S Ghai.
2013‐2016 Imagistx Inc. Title: Mul ‐centre trial (5 sites) of high resolu on transrectal ultrasound versus standard low resolu on transrectal ultrasound for the iden fica on of clinically significant prostate cancer. Amount: $218,280 CAD. [Grants] Principal Inves gator: C Pavlovich, S Ghai. Co‐ Inves gators: G Eure, V Fradet, ME Hyndman.
2013‐2016 Prostate Cancer Canada. Title: Studies in BRCA‐Associated Prostate Cancer (BRCACaP) and Personalized Cancer Medicine: A Pan‐Canadian Network. Amount: $515,000 CAD. [Grants] Principal Inves gator: R Bristow, D Vesprini. Collaborator(s): M Haider, S Narod, K Sridhar, K Chi, W Foulkes, P Boutros, T van der Kwast, F Saad.
2013‐2016 Movember Discovery Grant. Title: Hyperpolarized carbon‐13 imaging of advanced metasta c prostate cancer. Prostate Cancer Canada. Amount: $195,788 CAD. [Grants] Principal Inves gator: CH Cunningham. Collaborator(s): U Emminegger. Co‐Inves gator: M Haider.
2013‐2016 Prostate Cancer Canada. Discovery Grant. D2013‐28. Title: 18F‐FDG ‐PET/MR in high risk prostate cancer: a mul parametric approach. Amount: 199,558 CAD. [Grants] Principal Inves gator: U Metser. Collaborator(s): C Menard, M Jewe , R Bristow.
2013‐2016 US Department of Defense. Synergis c Transla onal Research Award. OC120440 and OC120440P1. Title: Targe ng Ovarian Cancer with Porphysome Nanotechnology. Amount: $470,000 USD. [Grants] Principal Inves gators: G Zheng, A Oza. Collaborator(s): U Metser, B Rosen, P Shaw.
2013‐2016 Ontario Ins tute for Cancer Research (OICR). HICT. Title: Imaging with 111In‐pertuzumab to Predict Response to Trastuzumab in HER2 Posi ve Metasta c Breast Cancer. Amount: $525,000 CAD. [Clinical Trials] Principal Inves gator: M Levine. Collaborator(s): R Reilly. Co‐Inves gator: C Caldwell.
2013‐2016 Ontario Ins tute for Cancer Research (OICR). HICT. Title: Assessment of Castrate Resistant Prostate Cancer Response Through Comprehensive Characteriza on using novel biomarkers (PET CRPC). Amount: $777,499.88 CAD. [Grants] Principal Inves gators: E Winquist. Collaborator(s): G Bauman, W Pavlosky, Z Kassam, A Allan, A Chambers, H Leong, S Ernst, S Ho e, S Mukherjee, J Butler,K Gulenchyn, G Pond, J Anthony, U Metser, K Jhaveri, M Noseworthy, I Rachinski.
2013‐2016 Juvenile Diabetes Research Founda on. Title: Canadian study of longevity in diabetes: discovering factors for success a er 50 years of diabetes. Amount: $802,204 CAD. [Grants]. Principal Inves gator: B Perkins. Collaborator(s): D Cherney (Co Principal Inves gator), M Brent, V Bril, H Keenan, N Paul.
2013‐2016 Canadian Ins tutes of Health Research (CIHR). Title: Evalua ng the effec veness of organized breast assessment among women screened in the Ontario Breast Screening Program. Amount: $463,733 (over 3 yrs) Principal Inves gators: AM Chiarelli. Co‐Inves gators: D Muradali, C Holloway, F O’Malley, ML Quan, L Mirea. Collaborators: L Chappell, B Fleming, A Hey, S Joanisse, A McMullen, C Rand, R Shumak, L Van Manen.
2013‐2016 Canadian Ins tutes of Health Research and Natural Sciences and Engineering Research Council ‐ Collabora ve Health Research Projects (CHRP). Title: Temperature measurement in cor cal bone and bone marrow during magne c resonance guided focused ultrasound thermo‐therapy in a porcine model. Amount: $454,646 CAD. [Grants] Principal Inves gator: JM Drake. Collaborator(s): J Amaral, M Temple, HL Cheng, S Sivaloganathan, B Alman, AC Waspe.
Department of Medical Imaging ‐ Annual Report 2014‐2015 85